Aug. 12 at 1:21 AM
$HBIO - Harvard Bioscience Inc. Common Stock - 10Q - Updated Risk Factors
HBIO flags heightened risks from significant debt, reliance on lender waivers for covenant breaches, stricter credit agreement terms, and looming refinancing deadlines; Nasdaq non-compliance threats now detailed, including bid price issues, potential reverse split, and delisting impacts. #Biotechnology #StockMarketCompliance #CreditCovenants #DebtManagement #FinancialRisk
🟢 Added 🟠 Removed
https://d-risk.ai/HBIO/10-Q/2025-08-11